The United Nations’ Commission on Narcotic Drugs last week decided to put off an important vote on scheduling recommendations related to cannabis.
It decided to instead vote at its reconvened sixty-third session in December 2020, “in order to preserve the integrity of the international scheduling system”. It seems some delegations didn’t have a clear understanding on the implications and consequences of the recommendations.
“We do regret that the CND was unable to take action on the WHO cannabis recommendations this week, given that Member States have been working hard since February 2019 to engage in an in-depth consultative process on the legal, administrative, social, and economic impacts of the recommendations,” said James A. Walsh, Principal Deputy Assistant Secretary, Bureau of International Narcotics and Law Enforcement Affairs.
The 63rd session of the Commission on Narcotic Drugs ended on March 7.
This can has been kicked down the road for quite a while. The USA’s Food and Drug Administration started requesting feedback regarding cannabidiol, a non-intoxicating cannabinoid, in response to a request from the World Health Organisation (WHO) for information in August 2017. Then in late 2017, the WHO Expert Committee on Drug Dependence (ECDD) declared current evidence does not justify the scheduling of cannabidiol.
To Read The Rest Of This Article By Terry Lassitenaz on Hemp Gazette
Published: March 10, 2020
Founder & Interim Editor of L.A. Cannabis News
SHARE
English
Spanish
